The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of myeloma cast nephropathy in the era of anti-CD38 monoclonal antibody-based frontline therapy: A retrospective cohort study.
 
Michael Sang Hughes
No Relationships to Disclose
 
Metodi Balev
No Relationships to Disclose
 
Jai Radhakrishnan
Consulting or Advisory Role - ANI Pharmaceuticals; Chinook GSK; Novartis; Travere Therapeutics
Speakers' Bureau - Amgen; GlaxoSmithKline
Research Funding - Bayer; Mineralys Therapeutics; Travere Therapeutics; Vertex
Expert Testimony - Gilead Sciences
 
Divaya Bhutani
Consulting or Advisory Role - Sanofi
Research Funding - Sanofi (Inst)
 
Markus Y. Mapara
Stock and Other Ownership Interests - Caelum Biosciences
Honoraria - Incyte; Ossium Health
Consulting or Advisory Role - Bluebird Bio; Crispr Therapeutics; Ossium Health; Vertex
Research Funding - Ossium Health
Patents, Royalties, Other Intellectual Property - Caelum Biosciences
 
Andrew Eisenberger
No Relationships to Disclose
 
Suzanne Lentzsch
Stock and Other Ownership Interests - Dianthus Therapeutics (I); Poseida (I)
Consulting or Advisory Role - Adaptive Biotechnologies; Alexion Pharmaceuticals; Bluebird Bio (I); BMS; Crispr Tx (I); GlaxoSmithKline; Incyte (I); Janssen; Karyopharm Therapeutics; Pfizer; Regeneron; Sanofi
Speakers' Bureau - BioAscent; Clinical Care Options; PeerView; RedMedEd.com
Research Funding - Sanofi
Patents, Royalties, Other Intellectual Property - Patent 11-1F4 mAb for use in AL Amyloidosis
Travel, Accommodations, Expenses - Regeneron
 
Rajshekhar Chakraborty
Consulting or Advisory Role - Adaptive Biotechnologies; Janssen; Sanofi Pasteur